Date updated:05-29-2008
The biotech sector is anticipating a big weekend for cancer drugs in the ASCO conference. What is the trade?

-
IMCL
N/a - $69.67
- 0.00
- $69.67
We’re talking about lung cancer, explains CNBC Pharmaceuticals Reporter Mike Huckman. Look for headline-grabbing test results out of ImClone (IMCL).

-
DNA
N/a - $80.43
- 0.00
- $80.43
Also keep an eye on Genetech (DNA), he says for two reasons 1) because the lung cancer data could have an impact on one of their drugs and Genentech should also deliver news on a breast cancer treatment.

-
LLY
Lilly Eli Co - $36.90
- -1.34%
- $36.91
As well as more details from Eli Lilly (LLY) on Alimta, its drug for lung cancer.

-
CELG
Celgene Corporati - $54.97
- -1.40%
- $53.81
In addition, Celgene (CELG) is another name to watch but keep in mind shares rallied when most of its study results were released two weeks ago.

-
BIIB
Biogen Idec Inc - $46.92
- -1.12%
- $46.20
As well as Biogen (BIIB) and Elan (ELN).

-
ELN
Elan Cp Plc Adr - $6.27
- -1.72%
- $6.24
As well as Biogen (BIIB) and Elan (ELN).
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Top 5 Small-Cap Stocks: N...
- » Echo5Joker's Portfolio
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 27, 2009 According to Jim Cramer, investors need to know the four enemies of all bull markets. On Wednesday’s “Mad Money” TV show...
By Roberto Pedone Posted on Nov. 27, 2009 According to CNBC’s “Fast Money” traders, the adjustment in the third-quarter GDP figure released on Tuesday from an exp...
By Jonas Elmerraji Posted on Nov. 25, 2009 With Thanksgiving fast approaching, retailers have one thing on their collective minds: Black Friday. After all, the day, whi...
By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...
A. *correction - 4-star rating, but it was
5 for a long time up until recently.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here is a list of some of the companies that will report earnings on Monday (Nov. 30, 2009). For some of the companies below, EPS estimates* are provided. * Analyst o... more
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 27, 2009. more
Analyst Downgrades or Estimate Reductions for Nov. 27, 2009. Read more here. more











Comments not available